Sep 21, 2015
LTX-315 paper published in Oncotarget
Lytix Biopharma's MoA paper describes LTX-315 as a mitochondrion-targeted oncolytic peptide.
The MoA paper is published in Oncotarget.
Lytix Biopharma's MoA paper describes LTX-315 as a mitochondrion-targeted oncolytic peptide.
The MoA paper is published in Oncotarget.